» Articles » PMID: 169866

Electron Spin Resonance Study of Changes During the Development of a Mouse Myeloid Leukaemia. I. Paramagnetic Metal Ions

Overview
Journal Br J Cancer
Specialty Oncology
Date 1975 Jul 1
PMID 169866
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

The blood, spleen and liver of mice were examined by means of electron spin resonance (e.s.r.), throughout the course of myeloid leukaemia induced by intravenous injection of leukaemic spleen cells. In blood, marked increases in the concentrations of iron transferrin and ceruloplasmin occurred within the first 3 days after injection. In the spleen, changes in the concentrations of paramagnetic copper and iron complexes were detectable by about the 5th day, before any measurable splenic enlargement, whilst in the liver changes were detectable by about the 8th day. The changes occurring in blood, spleen and liver during the development of leukaemia appear to be related and they are discussed in terms of iron transport.

Citing Articles

Electron spin resonance (ESR) spectrum of paraffin embedded human liver tissue. A possible method for the estimation of copper content.

Elek G, Lapis K, Rockenbauer A Histochemistry. 1979; 61(2):233-7.

PMID: 222716 DOI: 10.1007/BF00496535.


ESR study of development of RFM/Un murine myeloid leukaemia.

Dodd N, Silcock J Br J Cancer. 1978; 38(5):612-8.

PMID: 215181 PMC: 2009775. DOI: 10.1038/bjc.1978.257.


Electron spin resonance study of changes during development of solid yoshida tumour. II. Paramagnetic metal ions.

Dodd N, Silcock J Br J Cancer. 1976; 34(5):556-65.

PMID: 187210 PMC: 2025210. DOI: 10.1038/bjc.1976.211.


Electron spin resonance study of changes during the development of a mouse myeloid leukaemia. II. The ascorbyl radical.

Dodd N Br J Cancer. 1975; 32(4):451-5.

PMID: 174704 PMC: 2024765. DOI: 10.1038/bjc.1975.246.

References
1.
JELLIFFE A . Invited discussion: Value of fluctuations in the serum copper level in the control of patients with Hodgkin's disease. Natl Cancer Inst Monogr. 1973; 36:325-6. View

2.
Tessmer C, HRGOVCIC M, Thomas F, Fuller L, Castro J . Serum copper as an index of tumor response to radiotherapy. Radiology. 1973; 106(3):635-9. DOI: 10.1148/106.3.635. View

3.
HRGOVCIC M, Tessmer C, Minckler T, Mosier B, TAYLOR G . Serum copper levels in lymphoma and leukemia. Special reference to Hodgkin's disease. Cancer. 1968; 21(4):743-55. DOI: 10.1002/1097-0142(196804)21:4<743::aid-cncr2820210427>3.0.co;2-a. View

4.
MCDERMOTT J, Huber C, Osaki S, Frieden E . Role of iron in the oxidase activity of ceruloplasmin. Biochim Biophys Acta. 1968; 151(3):541-57. DOI: 10.1016/0005-2744(68)90001-6. View

5.
Warren R, JELLIFFE A, Watson J, Hobbs C . Prolonged observations on variations in the serum copper in Hodgkin's disease. Clin Radiol. 1969; 20(3):247-56. DOI: 10.1016/s0009-9260(69)80138-8. View